Director, Financial Planning & Analysis, European Markets at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

BS/BA or equivalent required, finance, accounting or a related field; MBA preferred
CPA or equivalent a plus (though not required)
Minimum 10-12 years of relevant Finance experience
Strong financial planning and analysis background and extensive experience with end-to-end business planning cycles, budgeting processes, demand forecasting, and profitability analyses
Solid understanding of commercial business models and broad understanding of Commercialization Finance operations is an advantage
Prior Commercialization P&L accountability, extensive FP&A experience, and US/International market experience
Strong business partnering skills
Excellent interpersonal and communication skills, strong ability to influence and lead in a matrixed organization, strong intercultural skills
Business Acumen: Strong and proven ability to operate as business co-owner. Ability to understand local and micro business dynamics, identify risks and opportunities
Collaboration: Ability to clearly communicate and story-tell; strong cross-matrix partnership skills; ability to influence and drive effective decision making, at times without explicit authority
Financial literacy: Strong business forecasting and scenario analysis skills, with an understanding of key accounting and reporting needs
Leadership: Demonstrate a growth and agile mindset, open to elevating financial and business discussions to focus on results; solving programs

Responsibilities

Lead and own the financial planning processes and timelines (Budget, Projections & Actuals), working closely with VP Finance, European Markets, European Market Finance Directors, Executive Director FP&A Commercialization HQ, as well as CFP&A Investor Relations and their teams
Drive transparent reporting/analysis of regional performance and financial results and provide region/market insights and outlook
Identify material risks and opportunities and actively participate in designing and executing response or contingency plans
Shape resource allocation across the Region to maximize value creation and partner closely with functional leaders to deliver targeted results
Drive continuous focus on evolving ways of working and improve/simplify processes and deliverables
Lead assigned projects, managing deliverables and expectations across a broad range of stakeholders
Lead the European Markets HQ Commercialization FP&A team
Provide financial oversight to drive improved business performance and facilitate timely decision making for the European Markets Commercialization organization

Skills

Financial Planning

FP&A

Budgeting

Projections

Actuals Reporting

Financial Analysis

Business Partnering

Leadership

Performance Analysis

Strategic Finance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free